Replimune
REPL
#5929
Rank
โ‚ฌ1.07 B
Marketcap
11,36ย โ‚ฌ
Share price
1.47%
Change (1 day)
135.77%
Change (1 year)

EPS for Replimune (REPL)

EPS in 2025 (TTM): -2,99ย โ‚ฌ

According to Replimune 's latest financial reports the company's current EPS (TTM) is -2,96ย โ‚ฌ. In 2026 the company made an earnings per share (EPS) of -2,93ย โ‚ฌ a decrease over its 2025 EPS that were of -2,66ย โ‚ฌ.

EPS history for Replimune from 2017 to 2025

Annual EPS

Year EPS Change
2026-2,93ย โ‚ฌ10.1%
2025-2,66ย โ‚ฌ-5.25%
2024-2,81ย โ‚ฌ8.36%
2023-2,59ย โ‚ฌ32.3%
2022-1,96ย โ‚ฌ29.14%
2021-1,52ย โ‚ฌ13.64%
2020-1,33ย โ‚ฌ15.79%
2019-1,15ย โ‚ฌ45.18%
2018-0,79ย โ‚ฌ155.74%
2017-0,31ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,25ย โ‚ฌ-57.77%๐Ÿ‡บ๐Ÿ‡ธ USA